Cargando…

Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland

BACKGROUND: Tirbanibulin 1% ointment is a new treatment for actinic keratosis (AK) on the face or scalp. A health economic model was developed as part of a submission to the Scottish Medicines Consortium to evaluate the cost-effectiveness of tirbanibulin compared to the most frequently prescribed tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dymond, Amy, Green, Will, Edwards, Mary, Pont, Maria Angeles Lopez, Gupta, Girish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170011/ https://www.ncbi.nlm.nih.gov/pubmed/37012513 http://dx.doi.org/10.1007/s41669-023-00410-5

Ejemplares similares

Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022)

Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
por: Kirchberger, Michael Constantin, et al.
Publicado: (2023)

1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses
por: Dao, Diem-Phuong D., et al.
Publicado: (2021)

Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Heppt, Markus V., et al.
Publicado: (2022)

1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study
por: IGLESIAS-PUZAS, Álvaro, et al.
Publicado: (2023)

Optimal treatment of actinic keratosis
por: Goldenberg, Gary
Publicado: (2013)

Retinoids for prevention and treatment of actinic keratosis*
por: Ianhez, Mayra, et al.
Publicado: (2013)

Actinic Keratosis: Rationale and Management
por: Dodds, Annabel, et al.
Publicado: (2014)

Virtual consultation for actinic keratosis
por: Dhariwal, Sukhjit, et al.
Publicado: (2020)

The Genomic Landscape of Actinic Keratosis
por: Thomson, Jason, et al.
Publicado: (2021)

Cost for the treatment of actinic keratosis on the rise in Australia
por: Perera, Eshini, et al.
Publicado: (2014)

Non-adherence to topical treatments for actinic keratosis
por: Shergill, Bav, et al.
Publicado: (2013)

Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
por: Thomas, Gareth J., et al.
Publicado: (2017)

Successful Treatment of Actinic Keratosis with Kanuka Honey
por: Mane, Saras, et al.
Publicado: (2018)

Current and emerging treatment strategies for the treatment of actinic keratosis
por: Berlin, Joshua M
Publicado: (2010)

Topical tirbanibulin eradication of periungual squamous cell carcinoma
por: Moore, Angela Yen, et al.
Publicado: (2021)

Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma
por: Abudu, Boya, et al.
Publicado: (2019)

Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
por: MORTON, Colin, et al.
Publicado: (2023)

The interpretation of clinical studies on the photodynamic treatment of actinic keratosis
por: Kelleher, Debra K., et al.
Publicado: (2012)

Cyclooxygenase-2 expression in actinic keratosis
por: Adamska, Kinga, et al.
Publicado: (2018)

Circumscribed Palmar Hypokeratosis With Superimposed Actinic Keratosis
por: Aukerman, Erica, et al.
Publicado: (2023)

Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013)

Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
por: Soini, Erkki J., et al.
Publicado: (2015)

Treatment of Actinic Keratosis: The Best Choice through an Observational Study
por: Yoo, Seung-Ah, et al.
Publicado: (2022)

Attitudes among dermatologists regarding actinic keratosis treatment options
por: Moretta, Gaia, et al.
Publicado: (2022)

Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
por: Mazur, Ewelina, et al.
Publicado: (2023)

Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018)

Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva
por: AL-HAGE, Jana, et al.
Publicado: (2023)

Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
por: Tampucci, Silvia, et al.
Publicado: (2019)

Tirbanibulin Attenuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling
por: Wang, Xin, et al.
Publicado: (2021)

Rapid resolution of recalcitrant basal cell carcinoma of the ear with topical tirbanibulin
por: Moore, Angela, et al.
Publicado: (2022)

Topical tirbanibulin resolves recalcitrant condyloma acuminata: Retrospective case series
por: Moore, Angela Yen, et al.
Publicado: (2023)

The medical treatment of the actinic keratosis and the skin tumours: photodynamic therapy (PDT)
por: Provenzano, E, et al.
Publicado: (2010)

New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012)

Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)

Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
por: Azin, Marjan, et al.
Publicado: (2022)

Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis
por: Kiss, Norbert, et al.
Publicado: (2022)

Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review
por: Arcuri, Domenico, et al.
Publicado: (2023)

Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States
por: Tan, Isabella J., et al.
Publicado: (2023)

Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate
por: Moreno, Ricardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g0nj8ugrdm9mouij007lprg39n